{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T10:12:45Z","timestamp":1784542365694,"version":"3.55.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["annemergmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Emergency Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.annemergmed.2026.06.021","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:11:14Z","timestamp":1784538674000},"page":"245-247","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is it Time to Lyse Our Use of \u201cLytics\u201d in Central Retinal Artery Occlusion?"],"prefix":"10.1016","volume":"88","author":[{"given":"Jaclyn","family":"DiBello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand K.","family":"Swaminathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annemergmed.2026.06.021_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/WNO.0000000000001027","article-title":"Thrombolysis for central retinal artery occlusion in 2020: time is vision","volume":"40","author":"Dumitrascu","year":"2020","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/j.annemergmed.2026.06.021_bib2","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1161\/STR.0000000000000366","article-title":"Thrombosis and Vascular Biology; Council on Hypertension; and Council on Peripheral Vascular Disease. Management of central retinal artery occlusion: a scientific statement from the American Heart Association","volume":"52","author":"Mac Grory","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/j.annemergmed.2026.06.021_bib3","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1001\/jamaneurol.2015.1578","article-title":"Intravenous fibrinolytic therapy in central retinal artery occlusion: a patient-level meta-analysis","volume":"72","author":"Schrag","year":"2015","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.annemergmed.2026.06.021_bib4","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1474-4422(25)00308-4","article-title":"Intravenous alteplase versus oral aspirin for acute central retinal artery occlusion within 4.5 h of severe vision loss (THEIA): a multicentre, double-dummy, patient-blinded and assessor-blinded, randomised, controlled, phase 3 trial","volume":"24","author":"Preterre","year":"2025","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.annemergmed.2026.06.021_bib5","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1056\/NEJMoa2508515","article-title":"A randomized trial of tenecteplase in acute central retinal artery occlusion","volume":"394","author":"Ryan","year":"2026","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annemergmed.2026.06.021_bib6","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1056\/NEJM198707163170304","article-title":"Equipoise and the ethics of clinical research","volume":"317","author":"Freedman","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.annemergmed.2026.06.021_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/1740774512450952","article-title":"Clinical equipoise and risk-benefit assessment","volume":"9","author":"Miller","year":"2012","journal-title":"Clin Trials"},{"key":"10.1016\/j.annemergmed.2026.06.021_bib8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1038\/nrclinonc.2011.211","article-title":"Equipoise: asking the right questions for clinical trial design","volume":"9","author":"Joffe","year":"2012","journal-title":"Nat Rev Clin Oncol"}],"container-title":["Annals of Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064426003884?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0196064426003884?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:59:22Z","timestamp":1784541562000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0196064426003884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S0196064426003884"],"URL":"https:\/\/doi.org\/10.1016\/j.annemergmed.2026.06.021","relation":{},"ISSN":["0196-0644"],"issn-type":[{"value":"0196-0644","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is it Time to Lyse Our Use of \u201cLytics\u201d in Central Retinal Artery Occlusion?","name":"articletitle","label":"Article Title"},{"value":"Annals of Emergency Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annemergmed.2026.06.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 by the .","name":"copyright","label":"Copyright"}]}}